PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Egypt.\', \'Technology and Innovation Commercialization Office (TICO), National Research Centre, Dokki, Egypt.\', \'Department of Immunology, Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt.\', \'Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.\', \'Division of Gastroenterology/Hepatology, Department of Medicine, University Hospital Osijek, Osijek, Croatia.\', \'Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3233/HAB-211513
?:doi
?:hasPublicationType
?:journal
  • Human antibodies
is ?:pmid of
?:pmid
?:pmid
  • 34958012
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.382
?:rankingScore_hIndex
  • 23
is ?:relation_isRelatedTo_publication of
?:title
  • Mini-review: The market growth of diagnostic and therapeutic monoclonal antibodies - SARS CoV-2 as an example.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all